依那西普:治疗小儿斑块型银屑病的新选择

Future Prescriber Pub Date : 2009-01-19 DOI:10.1002/fps.36

Steve Chaplin MSc, MRPharmS, Dr David Atherton MA, MB, BChir, FRCP

{"title":"依那西普:治疗小儿斑块型银屑病的新选择","authors":"Steve Chaplin MSc, MRPharmS, Dr David Atherton MA, MB, BChir, FRCP","doi":"10.1002/fps.36","DOIUrl":null,"url":null,"abstract":"<p>Psoriasis in children and adolescents can be disfiguring and adversely affect quality of life. A range of treatments are available that can control the condition, but not all patients respond or are able to tolerate the treatments. The anti-TNF alpha inhibitors are used effectively in adult psoriasis but are not currently licensed for use in children. The anti-TNF etanercept (Enbrel) has been studied in childhood psoriasis and is likely to gain a licence in the near future. In this article, the authors discuss current treatment approaches in childhood psoriasis and describe the efficacy, tolerability and potential place of etanercept in practice. Copyright © 2008 John Wiley & Sons, Ltd.</p>","PeriodicalId":100566,"journal":{"name":"Future Prescriber","volume":"9 3","pages":"6-10"},"PeriodicalIF":0.0000,"publicationDate":"2009-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/fps.36","citationCount":"0","resultStr":"{\"title\":\"Etanercept: a new option in paediatric plaque psoriasis\",\"authors\":\"Steve Chaplin MSc, MRPharmS, Dr David Atherton MA, MB, BChir, FRCP\",\"doi\":\"10.1002/fps.36\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Psoriasis in children and adolescents can be disfiguring and adversely affect quality of life. A range of treatments are available that can control the condition, but not all patients respond or are able to tolerate the treatments. The anti-TNF alpha inhibitors are used effectively in adult psoriasis but are not currently licensed for use in children. The anti-TNF etanercept (Enbrel) has been studied in childhood psoriasis and is likely to gain a licence in the near future. In this article, the authors discuss current treatment approaches in childhood psoriasis and describe the efficacy, tolerability and potential place of etanercept in practice. Copyright © 2008 John Wiley & Sons, Ltd.</p>\",\"PeriodicalId\":100566,\"journal\":{\"name\":\"Future Prescriber\",\"volume\":\"9 3\",\"pages\":\"6-10\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2009-01-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1002/fps.36\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Future Prescriber\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/fps.36\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future Prescriber","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/fps.36","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

儿童和青少年的牛皮癣会毁容并对生活质量产生不利影响。有一系列的治疗方法可以控制病情，但并不是所有的患者都对这些治疗有反应或能够耐受。抗tnf α抑制剂有效地用于成人牛皮癣，但目前尚未获准用于儿童。抗肿瘤坏死因子依那西普(Enbrel)已经在儿童牛皮癣中进行了研究，并可能在不久的将来获得许可。在这篇文章中，作者讨论了目前儿童牛皮癣的治疗方法，并描述了依那西普的疗效、耐受性和在实践中的潜在地位。版权所有©2008 John Wiley &儿子,有限公司

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Etanercept: a new option in paediatric plaque psoriasis

Psoriasis in children and adolescents can be disfiguring and adversely affect quality of life. A range of treatments are available that can control the condition, but not all patients respond or are able to tolerate the treatments. The anti-TNF alpha inhibitors are used effectively in adult psoriasis but are not currently licensed for use in children. The anti-TNF etanercept (Enbrel) has been studied in childhood psoriasis and is likely to gain a licence in the near future. In this article, the authors discuss current treatment approaches in childhood psoriasis and describe the efficacy, tolerability and potential place of etanercept in practice. Copyright © 2008 John Wiley & Sons, Ltd.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Future Prescriber

自引率

0.00%

发文量